[HTML][HTML] Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis

G Chen, Y Chen, J Hong, J Gao, Z Xu - Journal of Orthopaedic Surgery …, 2023 - Springer
Objective Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported
to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our …

[HTML][HTML] Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis

G Chen, Y Chen, J Hong, J Gao… - Journal of …, 2023 - josr-online.biomedcentral.com
Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported to improve
postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our work, we …

Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis

G Chen, Y Chen, J Hong, J Gao… - Journal of Orthopaedic …, 2023 - search.proquest.com
Objective Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported
to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our …

[HTML][HTML] Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis

G Chen, Y Chen, J Hong, J Gao… - Journal of Orthopaedic …, 2023 - ncbi.nlm.nih.gov
Objective Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported
to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our …

Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis.

G Chen, Y Chen, J Hong, J Gao… - Journal of Orthopaedic …, 2023 - search.ebscohost.com
Objective: Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported
to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our …

Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis

G Chen, Y Chen, J Hong, J Gao… - Journal of orthopaedic …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported
to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our …

Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis.

G Chen, Y Chen, J Hong, J Gao, Z Xu - Journal of Orthopaedic …, 2023 - europepmc.org
Objective Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported
to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our …

Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis.

G Chen, Y Chen, J Hong, J Gao, Z Xu - Journal of Orthopaedic …, 2023 - europepmc.org
Objective Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported
to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our …

[PDF][PDF] Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis

G Chen, Y Chen, J Hong, J Gao… - Journal of …, 2023 - josr-online.biomedcentral.com
Objective Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported
to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our …